Just speculating -
If I was the TGA considering provisional approval and doing my due diligence I might want to know that they have the capacity, intention, and funds available to provide the additional clinical data to satisfy the requirements within the provisional registration period.
Which would mean a yes from the FDA and funding organized first.
But what do I know??
- Forums
- ASX - By Stock
- PAR
- Where we at?
Where we at?, page-565
-
- There are more pages in this discussion • 139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
28.0¢ |
Change
-0.010(3.45%) |
Mkt cap ! $97.94M |
Open | High | Low | Value | Volume |
29.0¢ | 29.5¢ | 28.0¢ | $40.10K | 140.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 135929 | 28.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 20969 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 135929 | 0.280 |
1 | 22475 | 0.275 |
7 | 102859 | 0.270 |
2 | 384000 | 0.265 |
4 | 21233 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 20969 | 2 |
0.290 | 72464 | 1 |
0.300 | 3984 | 2 |
0.305 | 55100 | 3 |
0.310 | 22870 | 4 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |